Qsp 1.9 Here

The Quality Manager shall review the NCR. The disposition decision will fall into one of the following categories:

Traditional pharmacokinetic/pharmacodynamic (PK/PD) models struggle with complex, multi-pathway diseases (cancer, autoimmune disorders, fibrosis). QSP addresses this by coupling drug action with dynamic, mechanistic networks of signaling, metabolism, and immune response.